Valuation: Medpace Holdings, Inc.

Market Cap 16.33B 14.35B 13.39B 12.29B 23B 1,564B 23.57B 159B 62.1B 774B 61.3B 59.97B 2,675B P/E 2026 *
33.3x
P/E 2027 * 30.5x
Enterprise Value 15.52B 13.64B 12.73B 11.69B 21.87B 1,487B 22.41B 151B 59.05B 736B 58.29B 57.02B 2,544B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.98x
Free-Float
79.92%
Yield 2026 *
-
Yield 2027 * -
1 day+2.44%
1 week+10.76%
Current month+10.45%
1 month+9.39%
3 months+41.43%
6 months-1.37%
Current year+4.14%
1 week 568.31
Extreme 568.31
612.07
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Fiscal year

Director

66 0.0002%
6/30/26 Fiscal year

Director

72 0.0003%
6/30/26 Fiscal year

Director

56 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.44%+10.76%+30.59%+129.56% 15.94B
+2.61%+7.16%-0.93%+13.91% 47.88B
+1.90%+24.70%+27.25%+9.47% 40.55B
-1.60%-1.15%+388.84%+603.70% 39.09B
-0.98%+2.28%+7.02%+45.34% 36.75B
+1.47%+5.82%+5.76%+43.52% 27.96B
-0.94%+0.05% - - 16.77B
-1.14%+6.52%-3.80%-29.33% 13.81B
+0.18%-2.75%+3.22%+10.14% 13.55B
-2.34%+7.36%+31.58%+11.55% 11.58B
Average +0.16%+4.88%+54.39%+93.09% 26.39B
Weighted average by Cap. +0.48%+5.03%+70.91%+119.23%

Financials

2026 *2027 *
Net sales 2.85B 2.51B 2.34B 2.15B 4.02B 273B 4.12B 27.74B 10.85B 135B 10.71B 10.47B 467B 3.03B 2.66B 2.48B 2.28B 4.27B 290B 4.37B 29.44B 11.51B 143B 11.36B 11.12B 496B
Net income 503M 442M 412M 378M 708M 48.14B 726M 4.89B 1.91B 23.82B 1.89B 1.85B 82.35B 547M 480M 448M 411M 770M 52.35B 789M 5.32B 2.08B 25.91B 2.05B 2.01B 89.56B
Net Debt -802M -705M -658M -604M -1.13B -76.85B -1.16B -7.8B -3.05B -38.03B -3.01B -2.95B -131B -1.25B -1.1B -1.03B -943M -1.76B -120B -1.81B -12.18B -4.76B -59.35B -4.7B -4.6B -205B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
26-07-29 US$584.93 +2.44% 580,885
26-07-28 US$570.97 -3.12% 744,204
26-07-27 US$589.37 -2.00% 415,466
26-07-24 US$601.38 -0.73% 492,279
26-07-23 US$605.82 +14.71% 1,177,298
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
584.93USD
Average target price
581.83USD
Spread / Average Target
-0.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock